Skip to content Skip to footer
Menu Close
  • Home
  • About Us
  • Contact Us
Close
  • Home
  • About Us
  • Contact Us

Corrective and Preventive

Action (CAPA) Management

Institutionalizes corrective and preventive action management within a controlled, accountability-driven framework. Links actions to deviations, audits, incidents, and risk signals while enforcing effectiveness verification. Ensures sustained risk mitigation and strengthens continuous improvement culture while enhancing regulatory defensibility. The pharmaceutical company should have a CAPA system resulting from investigations of complaints, rejections, nonconformances, recalls, deviations, audits, and regulatory inspections.

Core Features

CAPA Initiation

  • Initiation of CAPA with documented cause or triggering reason
  • Supports initiation from Deviations, Audits, Incidents, QRM, and Market Complaints
  • Assignment of responsible owner and target timelines at initiation stage
  • Fully configurable, multi-level approval workflows based on the organizational structure

CAPA Implementation

  • Realtime tracking of CAPA action items with automated reminders and escalation for overdue tasks
  • Structured CAPA implementation workflow ensuring accountability
  • Linked actions across Deviations, Audits, Incidents, Complaints, and Risk modules
  • Approval checkpoints for CAPA review and decision validation

Enterprise Oversight & Continuous Improvement

  • Realtime dashboards and KPI monitoring for effective management review and decision making
  • Reinforces continuous improvement culture with systematic CAPA discipline
  • Enhances regulatory defensibility with complete, inspection-ready documentation
  • Centralized CAPA management enabling enterprise-wide visibility

Key Benefits

Supports faster and more effective decision making

Strengthens continuous improvement culture

Enhances regulatory defensibility

Accountability driven framework with full traceability

CAPA methodology results in product and process improvements

Business Benefits

Streamlines CAPA execution with structured, automated workflows that eliminate manual tracking gaps

Improves CAPA reliability by ensuring actions are completed consistently and on time

Enhances visibility and control through realtime monitoring and centralized reporting

Eliminates compliance risks associated with incomplete or poorly documented CAPA activities

Reduces overall cost of poor quality by minimizing failures, rework, deviations, and recalls

Strengthens enterprise wide continuous improvement with complete traceability and defensible CAPA documentation

45%

Reduction in CAPA Cycle Time

30–40%

Reduction in Repeat Quality Events

95%+

On Time CAPA Closure

20–35%

Reduction in Cost of Poor Quality

Start Your Digital Transformation Journey

Empower your organization with GMP compliant QMS, EBMR, LIMS, and Equipment Management solutions designed for Pharma 4.0.

📞 Contact Pharma Soft today to schedule a demo and discover how our platform can transform your regulated manufacturing operations.

Frequently asked questions

PharmaSoft is committed to empowering pharmaceutical and biotech teams with trusted, compliant, and fully validated digital solutions supported by expert guidance across quality, manufacturing, and laboratory operations.

CAPAs can be initiated from Deviations, Audit findings, Incidents, Market Complaints and Regulatory inspections.

After implementation, effectiveness check phase requires documented evidence that the corrective action has resolved the root cause with approval required before final CAPA closure.

Every CAPA phase (initiation, implementation, effectiveness check, closure) is assigned to named responsible parties with due dates, automated reminders, and escalation workflows.

CAPA is bi-directionally integrated with Deviations, Audits, Complaints, Incidents, Risk, and ensuring all quality event actions are consolidated.

Yes. CAPA trend reports including open/closed status, source analysis, cycle times, and effectiveness verification rates are available for QMS management review reporting.

Complete CAPA records with effectiveness verification, source linkage, trend analysis, and closure documentation provide regulators with auditable evidence of a functional continuous improvement system.

Each CAPA is assigned predefined timelines for every phase, with automated reminders and escalation alerts for overdue tasks, ensuring timely completion and regulatory compliance.

Yes. The system supports cross-functional collaboration by allowing multiple departments to participate in review workflows and implementation with role-based access control.

Yes. The system supports configurable, multi-level approval workflows for CAPA review and closure based on department, risk level, and organizational hierarchy, ensuring proper governance and compliance.

Yes. The CAPA module complies with 21 CFR Part 11 and EU Annex 11 requirements, supporting electronic signatures, audit trails, secure user authentication, and data integrity controls to ensure all CAPA records are secure, traceable, and audit-ready.